Clinical Trials Arena November 18, 2022
With Velocity’s support, Egin Research will expand its treatment areas for recruiting patients into clinical trials.
Integrated research site organisation Velocity Clinical Research has announced the acquisition of multi-site company Egin Research, marking its expansion into the UK.
With the expansion into Europe, Velocity now has 42 dedicated research locations.
The addition of the two sites of Egin Research increases Velocity’s site footprint in Europe to three, following its first purchase in Hamburg, Germany, in July this year.